Ikarian Capital’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.9M | Buy |
146,831
+16,831
| +13% | +$1.59M | 2.67% | 4 |
|
|
2025
Q1 | $8.25M | Buy |
130,000
+50,000
| +63% | +$3.17M | 1.02% | 9 |
|
|
2024
Q4 | $3.72M | Buy |
+80,000
| New | +$3.72M | 0.51% | 31 |
|
|
2024
Q3 | – | Sell |
-201,116
| Closed | -$2.91M | – | 129 |
|
|
2024
Q2 | $2.91M | Sell |
201,116
-174,194
| -46% | -$2.52M | 0.51% | 31 |
|
|
2024
Q1 | $6.04M | Buy |
375,310
+7,842
| +2% | +$126K | 0.66% | 21 |
|
|
2023
Q4 | $257K | Buy |
367,468
+48,877
| +15% | +$34.2K | 0.02% | 69 |
|
|
2023
Q3 | $214K | Buy |
318,591
+4,914
| +2% | +$3.3K | 0.03% | 66 |
|
|
2023
Q2 | $219K | Buy |
313,677
+85,000
| +37% | +$59.4K | 0.03% | 70 |
|
|
2023
Q1 | $4.59M | Sell |
228,677
-26,454
| -10% | -$531K | 1.04% | 19 |
|
|
2022
Q4 | $6.67M | Sell |
255,131
-60,000
| -19% | -$1.57M | 1.61% | 12 |
|
|
2022
Q3 | $193K | Buy |
315,131
+15,131
| +5% | +$9.27K | 0.04% | 55 |
|
|
2022
Q2 | $200K | Buy |
+300,000
| New | +$200K | 0.04% | 80 |
|